Dai HP - Search Results

1

Venetoclax with hypomethylating agents versus intensive chemotherapy in newly diagnosed acute myeloid leukemia with myelodysplasia related changes: A propensity score-matched analysis based on International Consensus Classification.

Wan CL, Liu YQ, Liu FT, Huang YH, Cao HY, Huang SM, Tan KW, Ge SS, Wang M, Liu MJ, Wang ZH, Li Z, Xue SL, Dai HP. Wan CL, et al. Among authors: dai hp. Blood Cancer J. 2024 Aug 23;14(1):144. doi: 10.1038/s41408-024-01130-7. Blood Cancer J. 2024. PMID: 39179571 Free PMC article. No abstract available.

2

FLT3-ITD with DNMT3A R882 double mutation is a poor prognostic factor in Chinese patients with acute myeloid leukemia after chemotherapy or allogeneic hematopoietic stem cell transplantation.

Tang S, Shen H, Mao X, Dai H, Zhu X, Xue S, Ding Z, Lu J, Wu D, Tang X. Tang S, et al. Int J Hematol. 2017 Oct;106(4):552-561. doi: 10.1007/s12185-017-2256-7. Epub 2017 Jun 14. Int J Hematol. 2017. PMID: 28616699

3

Ikaros family zinc-finger 1 mutation is an independent factor for the poor prognosis of adult B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic stem cell transplantation can improve clinical outcomes.

Tang S, Shen H, Qu C, Dai H, Zhu X, Xue S, Ding Z, Lu J, Wu D, Tang X. Tang S, et al. Bone Marrow Transplant. 2019 Feb;54(2):236-243. doi: 10.1038/s41409-018-0249-7. Epub 2018 Jun 25. Bone Marrow Transplant. 2019. PMID: 29942002

4

Effects of preemptive interferon-α monotherapy in acute leukemia patients with relapse tendency after allogeneic hematopoietic stem cell transplantation: a case-control study.

Lin XJ, Dai HP, Wang AJ, Chen F, Ma X, Sun AN, Zhu XM, Qiu HY, Jin ZM, Miao M, Xue SL, Mao XL, Wu DP, Tang XW. Lin XJ, et al. Among authors: dai hp. Ann Hematol. 2018 Nov;97(11):2195-2204. doi: 10.1007/s00277-018-3429-z. Epub 2018 Jul 11. Ann Hematol. 2018. PMID: 29995264

5

First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.

Tang X, Yang L, Li Z, Nalin AP, Dai H, Xu T, Yin J, You F, Zhu M, Shen W, Chen G, Zhu X, Wu D, Yu J. Tang X, et al. Am J Cancer Res. 2018 Jun 1;8(6):1083-1089. eCollection 2018. Am J Cancer Res. 2018. PMID: 30034945 Free PMC article.

6

Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.

Tang C, Chen F, Kong D, Ma Q, Dai H, Yin J, Li Z, Chen J, Zhu X, Mao X, Wu D, Tang X. Tang C, et al. J Hematol Oncol. 2018 Aug 16;11(1):103. doi: 10.1186/s13045-018-0649-6. J Hematol Oncol. 2018. PMID: 30115080 Free PMC article.

7

Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.

Tang X, Yang L, Li Z, Nalin AP, Dai H, Xu T, Yin J, You F, Zhu M, Shen W, Chen G, Zhu X, Wu D, Yu J. Tang X, et al. Am J Cancer Res. 2018 Sep 1;8(9):1899. eCollection 2018. Am J Cancer Res. 2018. PMID: 30323981 Free PMC article.

8

Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells.

Qu C, Li Z, Kang L, Wang Y, Dai H, Yin J, Chen G, Zhu M, Yao L, Xu T, Tian X, Xu Y, Chen J, Zhu X, Yu L, Wu D, Tang X. Qu C, et al. Bone Marrow Transplant. 2019 Jul;54(7):1138-1140. doi: 10.1038/s41409-018-0423-y. Epub 2019 Jan 10. Bone Marrow Transplant. 2019. PMID: 30631098 No abstract available.

9

Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia.

Ma Y, Qu C, Dai H, Yin J, Li Z, Chen J, Qiu H, Sun A, Miao M, Fu C, Jin Z, Zhu X, Wu D, Tang X. Ma Y, et al. Bone Marrow Transplant. 2020 Jun;55(6):1206-1208. doi: 10.1038/s41409-019-0677-z. Epub 2019 Sep 18. Bone Marrow Transplant. 2020. PMID: 31534194 No abstract available.

10

Donor origin CAR19 T cell infusion for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation.

Yang X, Dai H, Kang L, Qu C, Li Z, Yin J, Qiu H, Fu C, Han Y, Jin Z, Ma X, Zhu X, Yu L, Wu D, Tang X. Yang X, et al. Hematol Oncol. 2019 Dec;37(5):655-658. doi: 10.1002/hon.2682. Epub 2019 Oct 27. Hematol Oncol. 2019. PMID: 31656047 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters